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Introduction
Microglia are the main resident immunocompetent cells of the central nervous system (CNS); specialised myeloid cells which, along with other tissue-resident macrophage populations, are derived from erythro-myeloid progenitor cells originating in the yolk sac during early embryogenesis 1 . Although microglial cells display marked differences from other cells of the myeloid lineage, they express a range of 'classical' macrophage markers including the glycoproteins F4/80 and CD68, the fractalkine receptor CX3CR1, the integrin CD11b and the macrophage colony-stimulating factor-1 receptor (CSF1R) 2 . Microglia also express CD45, a pan-leukocyte marker, albeit in relatively lower levels compared to other CNS macrophage populations such as perivascular or meningeal macrophages, allowing the different cell populations to be distinguished phenotypically 3, 4 .
Microglia can adopt diverse morphologies depending on their functional states, the most commonly observed in the healthy brain being characterised by a small rod-shaped soma with elongated, ramified processes covered in fine protrusions that continuously survey the local microenvironment to detect perturbations in homeostasis 5 . Microglial function is critical to maintaining the CNS compartment in health and disease, with a range of functional states observed in the parenchyma that reflect the diverse roles of these dynamic cells. In the steady state, microglia phagocytose dying cells and debris to avoid generation of deleterious pro-inflammatory responses, prune excess neuronal connections in development, monitor synapses and control adult neurogenesis 6 . In the diseased or injured CNS they are the master regulators of the neuroimmune response and control the inflammatory status of the brain 6 . Whilst significant advancements have been made in the understanding of microglial functions, there are many aspects of their basic physiology that remain incompletely understood. Included amongst these are the mechanisms regulating the homeostatic composition and turnover of the microglial population from development to ageing. In this review we will recapitulate existing knowledge of the mechanisms regulating the dynamics of this cell population under physiological conditions, aiming to understand their roles during homeostasis and disease.
Developmental origins of the microglial population
Historically, the developmental origins of microglia have been the subject of intense debate, with hypotheses of mesodermal or monocytic origin dominating the field 7 until fate-mapping studies confirmed that these cells are derived from erythro-myeloid progenitors (EMPs) originating in the yolk sac (YS) 8 . The yolk sac origin of the microglial population was initially suggested by Alliot, et al. 9 , who demonstrated the presence of F4/80 + /CD11b + 'microglial progenitors' in the brain at embryonic day (E) 8.0 after their appearance in the yolk sac. The authors observed an average of three microglial progenitors in the brain primordium at E8.5, which were postulated to undergo massive proliferation to produce 1200 cells by E10.5. Definitive haematopoiesis begins at E10.5 in the aorta-gonad-mesonephros (AGM) region of the embryo, producing haematopoietic stem cells (HSCs) that migrate to the foetal liver and bone marrow before differentiating into a multitude of myeloid cell lineages 2 . The presence of microglia in the embryonic brain at E9.5 precedes this stage of haematopoiesis, suggesting an alternative origin for microglial precursors.
Primitive haematopoiesis occurs from E7.0 to E9.5 in the yolk sac, giving rise to primitive macrophages and erythrocytes, including a subset of EMPs, which differentiate into microglial cells 8, 10 ( Figure 1A ). These immature uncommitted CSF1R + c-kit + CD45 low AA4.1 + progenitors initiate a core macrophage transcriptional program and develop into 'premacrophages' (pMacs), upregulating expression of CSF1R, CX3CR1, and Fc gamma receptors, amongst other markers 1, 11 ( Figure 1A) . pMacs colonise the whole embryo from E9.5 in a CX3CR1-dependent manner, giving rise to all resident tissue macrophage populations through induction of tissue-specific transcriptional programs 1 . From E10.5, pMacs in the brain differentiate into microglia, downregulating expression of Timd4 and CD206 whilst upregulating expression of the microglial-specific transcription factors Sall1 and Sall3 1 . Fate-mapping studies have convincingly shown that these embryonic cells, seeding the prenatal, brain persist into adulthood to form the resident microglial population in the adult brain 8, 12 .
Microglial cells develop in three temporal stages, in synchrony with the brain (early, pre-, and adult microglia), which are governed by distinct regulatory circuits 13 . For example, the transcription factor MAFB coordinates the adult microglia program, with its knockout leading to disruption of homeostasis 13 .
Microglia reach its adult transcriptional identity by the second postnatal week, as demonstrated profiling TMEM119 + microglia, a remarkably specific marker of these cells 14 .
From an initial limited number of infiltrating progenitors, the microglial population expands rapidly by proliferation, colonising all brain regions by birth.
During the postnatal period, microglial numbers increase 2.2-fold, peaking at postnatal day 14 (P14) 15 . However, it remained unclear whether proliferation of the resident cell population alone accounts for this increase in cell numbers, or whether blood-derived monocytes infiltrate the parenchyma and differentiate into microglia 9 . To address this, our group utilised lentiviral vectors driving the expression of fluorescent proteins to label and track haematopoietic cells. In utero injection of vectors to the foetal liver at E14, when the liver is the main haematopoietic organ, allows specific labelling of haematopoietic cells produced at this developmental stage, which could then be analysed during the perinatal period. Infiltrating monocytes can be observed in the brain parenchyma from P0, reaching a peak at P3 ( Figure 1B) . From P6 to adulthood, these monocytes dramatically decline in number due to a prominent apoptotic response, with few cells surviving in the adult brain 16 ( Figure 1B ). These data indicate that monocyte infiltration and differentiation do not contribute to the postnatal expansion of the microglial population, providing further support for the YSorigin of adult microglial cells. However, it remains unknown if and how these monocytes contribute to postnatal development of the CNS. By six weeks of age, the microglial cell numbers have been refined to the density maintained throughout adulthood 15, 16 .
Microglia play an important role in embryonic and postnatal development of the brain. During brain development, microglia display an amoeboid morphology typically associated with phagocytic functions 17, 18 . It has been shown that microglia in the prenatal brain actively phagocytose neural precursors cells (NPCs) during the late stages of cortical neurogenesis, regulating the thickness of the neocortex 19 . Selective depletion of microglia using clodronate liposomes or suppression of microglial activation results in a significant increase in the number of NPCs, presumably through a reduction in phagocytosis, which may affect the cytoarchitecture of the brain 19 . Absence of microglia during early embryonic stages also results in abnormal outgrowth of dopaminergic neurons to the striatum and perturbed localisation of a subset of neocortical interneurons 20 . These data demonstrate the importance of maintaining microglial dynamics during development, as the physiological changes associated with their loss of function could be implicated in the pathogenesis of neurodevelopmental disorders 21, 22 . The phagocytic role of microglia in the healthy brain continues into adulthood, mostly restricted to the hippocampal neurogenic niche. The generation of an excess of hippocampal early neural precursor cells leads to an increased number of apoptotic cell, which are rapidly and efficiently removed by microglia in a non-inflammatory fashion 23 . Although microglia can accomplish this task even after significant increases in cell death, prolonged rates of apoptosis caused by an epileptogenic injury impair the phagocytic efficiency of microglia, further contributing to tissue damage 24 .
Using Csf1r -/-mice, Erblich, et al. 25 demonstrated that microglial function in normal brain development is most important during the early postnatal period.
At E16, no gross morphological changes are observed in the absence of microglia, however by the third postnatal week there is significant enlargement of the lateral ventricles and reduction in the size of the cortex, olfactory bulbs and hippocampus. An increase in neuronal density in the cortex was also observed, which could be attributed to increased presence of neural progenitor cells in the absence of microglia. However, the authors report no changes in the total number of neurons, suggesting that enlargement of the ventricles occurred as a result of hydrocephaly, which then caused pressure-induced compaction of the cortex 25 . These morphological changes coincide with the timeframe of the postnatal refinement of the microglial population 15 ; developmental apoptosis during the first two postnatal weeks results in increased cellular debris that would usually be cleared by microglia, the population of which is undergoing significant expansion during this time. In the absence of microglia, due to CSF1R deficiency, the lack of phagocytosis could lead to a build-up of debris that perturbs normal cerebrospinal fluid drainage, resulting in hydrocephaly; however, this has not been investigated by subsequent studies. Overall, compelling evidence supports that microglia are critical for the correct development of the brain, evidenced by the fact that its depletion during neonatal development leads to persistent and several behavioural abnormalities 26, 27 .
Microglia are also able to actively engulf synaptic material and modulate synapse numbers in a CX3CR1-CX3CL1-dependent manner during postnatal development.
CX3CR1 -/-mice have a significant, but transient, decrease in microglial density in the postnatal brain, which correlates with increased spine density and altered electrophysiological activity 28 , suggestive of reduced synaptic pruning and delayed development of the brain circuitry. Lack of microglial-mediated synaptic pruning has long-term effects on brain connectivity, evidenced by synaptic dysfunction and reduced functional connectivity between brain regions in CX3CR1 -/-mice, resulting in behavioural deficits 29 . CX3CL1-CX3CR1 signalling by microglia is also important in providing trophic support for neurons during early postnatal development 30 , highlighting the importance of this signalling pathway for neuron-microglia crosstalk throughout development. The classical complement cascade, which typically functions to target cellular debris for removal by the immune system, has also been implicated in microglial-mediated synaptic pruning in the retinogeniculate system during postnatal development. 
Microglial dynamics in the adult brain
The microglial population in the adult brain is highly heterogeneous, accounting for between 5% and 12% of the total population of glial cells in the healthy murine CNS 33 . Cell density remains stable throughout the lifetime of the mouse 16 , with a higher density present in grey matter-enriched regions compared to white matter 33 . In comparison, the human CNS has a higher cell density in the white matter, with microglia making up 0.5% to 16.6% of the total cells in the brain 34 . In addition to heterogeneity in cell density, microglia have regionally distinct transcriptional identities, with a degree of variability comparable to that seen in the transcriptomes of different peripheral macrophage populations 35 .
Microglia from the cortical and striatal regions are relatively similar, whereas cerebellar microglia have a distinct transcriptomic profile in the healthy adult Hippocampal microglia, which display an 'intermediate' profile between cortical/striatal and cerebellar microglia in the young brain, have a more similar transcriptome to cortical and striatal microglia in the aged brain 35 . An agerelated shift in the transcriptional identity of human glial cells has recently been demonstrated using post-mortem tissue, with an upregulation of microglialspecific genes found across multiple brain regions in the aged brain 36 . It is thought that heterogeneity in the transcriptional identity of microglia may underlie the region-specific demands of brain tissue under homeostatic conditions. Heterogeneity in the gene expression of immunoregulatory markers corroborates previous evidence demonstrating region-specific differences in their cell-surface expression 37 . This immunological diversity of microglia across the CNS is interesting in the context of their potential functions in neurodegenerative conditions, which are characterised by a region-specific pattern of pathology. Despite differences in the transcriptomes of microglia across brain regions, Hickman, et al. 38 demonstrated that all cells express a 'core profile' of genes, including CX3CR1, P2ry12, encoding a purinergic receptor that regulates microglial activation 39 , Trem2, which functions in microglial phagocytosis 40 , Hexb, encoding a subunit of the lysosomal enzyme β-hexosaminidase 41 and Tmem119, a transmembrane protein of unknown function in microglia 42 . Tmem119 expression has recently been validated to be a useful experimental tool to distinguish resident microglia from other tissue resident macrophages, meningeal and perivascular macrophages in the CNS 14 .
This core profile transcriptionally defines microglia and distinguishes them from other resident macrophage populations and CNS cells 14, 38, 43 .
The mechanisms by which microglial cell density is maintained in the healthy brain has been the subject of much controversy, with two main conflicting hypotheses; firstly, that the self-renewal of the resident cells is responsible for the maintenance of the population, or secondly that peripheral bone marrow derived cells (BMCs) infiltrate the parenchyma and differentiate into microglia.
The relative contributions of self-renewal and infiltration to the maintenance and/or expansion of the microglial population in health and under disease conditions have been investigated using bone marrow chimera studies 44, 45 .
However, increased blood-brain barrier (BBB) permeability and numbers of infiltrating BMCs are caused by the irradiation protocols used in these studies, thus confounding the interpretation of experimental results. The use of surgical parabionts, which share a joined circulatory system, allows for the contribution of circulating cells from one animal to the other to be analysed under nearphysiological conditions without lethal irradiation or transplantation. In healthy adult parabiotic mice, there was no recruitment of circulating progenitors to the microglial pool 46 . These results were in stark contrast to mice subjected to myeloablation and bone marrow transplantation, suggesting that recruitment of circulating monocytes to the CNS only occurs following experimental preconditioning. Under normal physiological conditions, the evidence suggests that microglia, like other resident tissue macrophage populations 52 , are maintained by self-renewal of resident cells in the steady state 53 . Microglial proliferation is a complex process regulated by many endogenous and exogenous factors. The CSF1R pathway is a key regulator of microglia proliferation in both the healthy and diseased CNS. CSF1R, encoded by the c-fms proto-oncogene, is expressed on both surveillant and activated microglia and is activated through binding of its ligands, colony-stimulating factor-1 (CSF1) and interleukin-34 (IL-34). Csf1r -/-mice have impaired development of YS-derived macrophage and microglial populations, with ~99% reduction in microglial numbers 8 , whereas deficiency in CSF1 or IL-34 leads to a ~30% 8 or ~50% 54 reduction in microglia, respectively. This suggests that while CSF1R is crucial for cell survival, the two ligands may have complementary functions. Upregulation of cell cycle-associated proteins, including proliferating cell nuclear antigen (PCNA), cyclin A and cyclin D, in the presence of CSF1 provides evidence for the mitogenic capability of the CSF1R pathway 55 , whilst its pro-survival signalling is mediated through activation of AKT kinase which directly phosphorylates and inhibits pro-apoptotic proteins as well as inhibiting activity of transcription factors that induce expression of proapoptotic genes 56 . Pharmacological blockade of CSF1R inhibits microglial proliferation in the healthy brain 16 and can induce apoptosis, resulting in depletion of ~99% of the population 57 .
The requirement for CSF1R signalling in the survival of the microglial population in the healthy adult brain has recently been demonstrated following pharmacological blockade of the receptor. PLX3397, a specific CSF1R inhibitor, reduced microglial numbers in the healthy brain by more than 90% after 7 days of treatment and almost completely depleted the population following longer treatment regimens 57 . The authors demonstrated that this reduction in cell numbers was not simply due to reduced proliferation but due to induction of apoptosis, evidenced by expression of active caspase-3 and positive propidium iodide staining. In this model, the microglial population began to reconstitute 3 days after stopping treatment, however repopulating cells display different morphology and expression of cell markers from control microglia, including transient expression of CD34 and c-Kit, markers of HSCs, and nestin, a marker of stem cell populations. By 14 days of recovery, microglial numbers, phenotype and morphology were indistinguishable from that in control brains 57 . Similar results were obtained after transgenic ablation of microglia: the microglial population is rapidly reconstituted by proliferation of resident cells. The use of a CX3CR1 CreEr -based system crossed with an inducible diphtheria toxin receptor (iDTR) system allowed specific ablation of microglial cells following tamoxifen and diphtheria toxin injections 58 . An 80% reduction in microglia was observed 3 days after induction, but after 14 days cell numbers returned to baseline levels.
In agreement with the pharmacological depletion model, after the transgenic ablation of microglia pools of resident cells, which rapidly proliferate to colonize the parenchyma, rapidly reconstituted the population. These CNS-derived microglia also expressed nestin, however this expression is transient and is no longer seen once cell numbers have returned to normal at day 14. In the steadystate, nestin is expressed by neural stem cells 59 , pericytes 60 and NG2 + oligodendrocyte precursor cells 61 within the CNS, with expression rarely found in other cell types 62 . Genetic ablation of microglia was associated with a 'cytokine storm' in the brain, evidenced by increased expression of proinflammatory cytokines, chemokines and co-stimulatory molecules 58 .
The aforementioned studies are repopulation paradigms, thus it is possible that expression of nestin on microglia is induced only following disruption of population homeostasis, as microglial expression of nestin under physiological conditions has not yet been reported 35, 38, 43 , and in the steady state proliferating microglia do not express nestin 16 . Therefore, these data suggest that nestin expression in microglia reflects a transient repopulating phenotype, rather than a subpopulation of 'microglial progenitor cells' 63 . Furthermore, the cytokine storm observed by Bruttger et al. highlights how far from a physiological system these paradigms are, as the inflammatory milieu of the CNS is markedly affected following massive microglial cell death. However, they do support previous data indicating that proliferation of CNS resident cells contributes to the resident microglial population 53 .
Maintenance of the microglial population by slow turnover of long-lived cells has been assumed for many years, since Lawson, et al. 53 reported a low turnover rate of 0.05% of microglia using 3 H-thymidine labelling combined with F4/80 immunohistochemistry. However, as acknowledged by the authors at the time, limitations associated with this method are likely to have led to an underestimation of the proliferation rate. These studies have since been revisited using more sensitive techniques, such as incorporation of BrdU, which is considered to be the 'gold standard' in the field. We have shown that the turnover rate of mouse microglia is much higher than expected, with an average of 0.69% of the population proliferating at any one time, allowing for an estimated complete renewal of the population once every 96 days 16 ( Figure 1C ).
In order to maintain a stable cell density throughout lifetime, there is a tight coupling between proliferation and apoptosis ( Figure 1C) , with cells more likely to proliferate in the vicinity of a dying cell immediately after it has undergone apoptosis, as evidenced by chronic two-photon microscopy 16 . This leads to a constant reorganisation of the microglial landscape, challenging the idea of individual cells being long-lived, which has implications for the concept of 'microglial memory'. The idea that cells can remember the particular signals or activity within its local microenvironment and use this to shape the activity of surrounding cells, for example in the monitoring and modulation of specific synapses 64 or the phenomenon of microglial priming 65 , needs to be revisited.
With cells turning over more rapidly than previously thought, it is likely that memory is stored within individual cells thanks to epigenetic modification or perhaps elsewhere in the neural/glial network.
Microglial dynamics in the diseased brain
The role of the innate immune system in the pathogenesis of neurodegenerative diseases is complex and not fully understood. Evidence suggests that neuroinflammation is a key component driving disease progression in a number of neurodegenerative conditions, however its precise role, and the exact functions of microglial cells in disease aetiology, are still unclear 6 . In addition to the debate of self-renewal or infiltration maintaining the microglial population in the healthy brain, there is controversy over the roles of resident microglia and infiltrating monocytes in the diseased brain.
In many neurodegenerative conditions, including AD, prion disease and amyotrophic lateral sclerosis (ALS), significantly increased numbers of microglia are present within the parenchyma [66] [67] [68] . Bone marrow chimera studies have shown that BMCs can be actively recruited in some disease models, however the limitations associated with irradiation protocols confound interpretation of these data. Ajami, et al. 46 demonstrated that in both facial nerve axotomy (acute) and ALS (chronic) models of neurodegeneration, bone marrow-derived cells do not contribute to microgliosis in the absence of irradiation. This was corroborated by evidence demonstrating that the increased production of chemo-attractants, including CCL2, after injury or neurodegeneration in the CNS is not sufficient to promote monocyte infiltration across an intact BBB 47 .
Whether or not the BBB is compromised in neurodegenerative conditions remains controversial 69, 70 , thus evidence indicating a parenchymal role for peripheral monocytes under pathological conditions must be interpreted with care. In Ccr2 -/-mice, which have a significantly reduced population of circulating monocytes, the expansion of the microglial population in response to prion disease occurs to a similar level as that in wild-type mice 71 . Further studies in APP/PS1 mice, a model of AD-like pathology, indicate that bone marrow-derived cells do not enter the parenchyma in the absence of pre-conditioning by irradiation 72 , providing evidence that circulating monocytes do not contribute to microgliosis under pathological conditions. Evidence indicating that proliferation of resident cells is solely responsible for the increased cell density observed in neurodegenerative conditions comes from studies utilizing CSF1R inhibitors as a therapeutic intervention. In murine models of prion 66 , AD 67 and ALS 73 , the use of CSF1R inhibitors significantly reduce microglial proliferation, thus decreasing cell numbers in the parenchyma.
In the ME7 murine model of prion disease, treatment with the selective CSF1R inhibitor GW2580 reduces microglial proliferation in addition to slowing the progression of neurodegeneration and alleviating behavioural deficits 66 . The use of this inhibitor in the SOD1 G93A model of ALS also attenuated disease progression, reducing the degeneration of motor neurons and extending survival 73 . Treatment with the CSF1R inhibitors GW2580, PLX3397 74 or PLX5622 75 in the APP/PS1 67 , 5xfAD 76 and 3xTg-AD 75 models of AD, respectively, improved learning and memory deficits despite having no impact on amyloid-β burden in the brain. Systemic LPS treatment was also associated in reduced expression of proinflammatory cytokines in GF mice, when compared to wild-type LPS-treated mice 78 .
Whilst these models of increased microglial numbers suggest that there is an impairment of the brain's immune response, they are likely to also be influenced by the systemic immune response, as the described modifications also affect the systemic compartment, with the immune response likely to be missregulated at baseline and upon stimulation. De, et al. 77 suggest that it is the presence of increased CSF1, not increased cell numbers, that impacts the microglial response to LPS, as this has previously been shown in vitro 79, 80 . Erny, et al. 78 suggests that the lack of complex gut microbiota affects the ability of microglia to initiate an immune response as opposed to impairment by increased cell numbers. Our recent studies have aimed at shedding light into the impact of increased microglial density in the brain, using Vav-Bcl2 mice 16 . These mice have a 40%
increase in microglial density in the adult brain, with a significant increase in the CD45 hi microglial population compared to WT, thanks to prevented apoptosis through overexpression of Bcl-2 in cells from the myeloid lineage 16 . The transcriptional signature of microglia derived from Vav-Bcl2 is characterised by a dysregulated metabolic and inflammatory response, when compared to wildtype microglia, although the neuronal and astroglial populations are unaffected 16 . Although these studies provide a useful framework for understanding the impact of increased microglial numbers in brain physiology, the effects of selectively increasing the number of microglia in the brain remains to be fully established.
The impact of reduced numbers of microglia has been investigated in more detail, due to the availability of multiple pharmacological and transgenic tools to reduce or deplete the population, as recently reviewed by Waisman et al 63 . Over 80% depletion of microglial numbers has been attained using different models:
Asai, et al. 81 and Elmore, et al. 57 58 , however the authors reported that microglial numbers returned to normal levels after 14 days. Pharmacological depletion of microglial numbers in the absence of pathology leads to a reduction in basal expression of pro-and anti-inflammatory cytokines in the CNS 57, 81 , whereas genetic depletion results in generation of a substantial proinflammatory response 58 . However, these experimental paradigms result in death of almost all of the microglial population, likely altering the inflammatory tone and confounding the ability to draw interpretations of how the inflammatory status of the CNS would be affected by reduction of microglial numbers alone. The effect of microglial depletion on cognitive functions is debated, with studies reporting deficits in learning and memory after seven days of depletion 82 , but no deficits in cortical and hippocampal learning and memory, motor function or anxiety-related behaviour seen after three weeks of depletion 57, 83 . Interestingly, CSF1R haploinsufficiency leads to elevated microglial numbers and cognitive, sensorimotor deficits and depression and anxiety-like behaviour 84 , suggestive of a link of microglial density with behaviour. Loss of the microglial population appears to alter baseline, as well as learning-dependent, neuronal spine density and remodelling, along with expression of synaptic proteins 82 . Finally, the innate immune response is impaired in the absence of microglia, as evidenced by a significant reduction in production of proinflammatory cytokines following LPS treatment 57, 83 .
In contrast to other depletion models, a significant upregulation of proinflammatory genes is found in CX3CR1 CreER -iDTR mice following microglial depletion. As all of these models induce substantial cell death in the CNS, it is possible that other CNS-resident cells, such as astrocytes, respond to this disruption of homeostasis. Elevated numbers of astrocytes were observed in the CX3CR1 CreER -iDTR model 58 , however this population remained unaffected after PLX3397 treatment 57 ; therefore it remains unclear how microglial depletion impacts other cell populations within the parenchyma. Whilst these studies are interesting in terms of investigating the impacts of having no microglia in the brain, it remains unknown how long-term gradual depletion of microglia would impact development, physiology, homeostatic functions and neuroinflammation in the CNS. 
Conclusions

